Concepedia

Dany Badibanga Musungaie

DB

4

Publications

5.4K

Citations

4

H-Index

2019

Active since

Affiliations

Baker Heart and Diabetes Institute(Current)

Hamilton Health Sciences

St. Michael's Hospital

Technische Universität Dresden

University of Latvia

Dany Badibanga Musungaie is an author at Baker Heart and Diabetes Institute specializing in medicine, diabetes, and metabolic syndrome.

Top concepts

Publications per year

2019–2021

4

Publications

4

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Angélica Jayk Bernal, Monica Maria Gomes da Silva, Dany Badibanga Musungaie et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults

Yoseph Caraco, Gordon Crofoot, Pablo Andrés Moncada et al. · NEJM Evidence · 2021 · 96 citations

, , +14

Rows per page

1–4 of 4